AGER and Alzheimer disease: Nevertheless, sLRP is oxidized in patients with AD, which decreases the binding affinity for Aβ while increasing the free Aβ in the plasma, which may result in an increase in the amounts of Aβ entering the brain through RAGE (Deane et al., 2012; Seok et al., 2019).